On January 31, 2017, it was revealed that Psychemedics Brasil Exames Toxicologicos Ltda., Psychemedics' local representative in Brazil, was ordered to compensate Omega Laboratories, Inc. USA for losses caused by anticompetitive practices used for "preventing other companies from accessing (the) market," on January 20, 2017. Following this news, Psychemedics stock dropped during intratrading on January 31, 2017.
If you are aware of any facts relating to this investigation, or purchased Psychemedics shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/pmd. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-psychemedics-corporation-pmd-300399703.html
SOURCE Bronstein, Gewirtz & Grossman, LLC